CN111056994A - 一种维莫德吉的制备方法 - Google Patents
一种维莫德吉的制备方法 Download PDFInfo
- Publication number
- CN111056994A CN111056994A CN201811202285.1A CN201811202285A CN111056994A CN 111056994 A CN111056994 A CN 111056994A CN 201811202285 A CN201811202285 A CN 201811202285A CN 111056994 A CN111056994 A CN 111056994A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- vismodegib
- reaction
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811202285.1A CN111056994B (zh) | 2018-10-16 | 2018-10-16 | 一种维莫德吉的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811202285.1A CN111056994B (zh) | 2018-10-16 | 2018-10-16 | 一种维莫德吉的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111056994A true CN111056994A (zh) | 2020-04-24 |
CN111056994B CN111056994B (zh) | 2021-08-17 |
Family
ID=70296469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811202285.1A Active CN111056994B (zh) | 2018-10-16 | 2018-10-16 | 一种维莫德吉的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111056994B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0318845A2 (de) * | 1987-12-04 | 1989-06-07 | BASF Aktiengesellschaft | Verfahren zur Herstellung von substituierten Pyridinen |
US20070072833A1 (en) * | 2005-09-29 | 2007-03-29 | Wendt Michael D | Survivin inhibitors |
EP2468726B1 (en) * | 2010-12-06 | 2013-08-28 | Siena Biotech S.p.A. | Compound for the treatment of tumours and tumour metastases |
CN107200708A (zh) * | 2017-05-27 | 2017-09-26 | 新发药业有限公司 | 一种维莫德吉的制备方法 |
-
2018
- 2018-10-16 CN CN201811202285.1A patent/CN111056994B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0318845A2 (de) * | 1987-12-04 | 1989-06-07 | BASF Aktiengesellschaft | Verfahren zur Herstellung von substituierten Pyridinen |
US20070072833A1 (en) * | 2005-09-29 | 2007-03-29 | Wendt Michael D | Survivin inhibitors |
EP2468726B1 (en) * | 2010-12-06 | 2013-08-28 | Siena Biotech S.p.A. | Compound for the treatment of tumours and tumour metastases |
CN107200708A (zh) * | 2017-05-27 | 2017-09-26 | 新发药业有限公司 | 一种维莫德吉的制备方法 |
Non-Patent Citations (1)
Title |
---|
SASAKI, ISABELLE , ET AL.: ""Facile Synthesis of Cyclometalated Ruthenium Complexes with Substituted Phenylpyridines"", 《 EUROPEAN JOURNAL OF INORGANIC CHEMISTRY》 * |
Also Published As
Publication number | Publication date |
---|---|
CN111056994B (zh) | 2021-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5138386B2 (ja) | 置換ビフェニル類の製造方法 | |
CN107573342B (zh) | 一种1,1’-乙撑-2,2’-联吡啶二氯盐的制备方法 | |
NO331656B1 (no) | Framgangsmate for syntetisering av camptothesin relaterte forbindelser | |
CN106045969B (zh) | 一种卡比替尼的合成方法 | |
KR20150072408A (ko) | 5-(2,6-디-4-모르폴리닐-4-피리미디닐)-4-트리플루오로메틸피리딘-2-아민의 개선된 제조 방법 | |
WO2006016510A1 (ja) | 2-アミノ-5-ヨード安息香酸の製造方法 | |
CN115181066B (zh) | 一种6-氯-2-甲基-2h-吲唑-5-胺的合成方法 | |
CN105153149A (zh) | 一种选择性激酶抑制剂Palbociclib的制备方法 | |
CN111056994B (zh) | 一种维莫德吉的制备方法 | |
Cho et al. | Synthesis and antiproliferative activity of new aminoisoquinolinylurea derivatives against melanoma cell line | |
CN106674084B (zh) | 一种2-异丙基氧基-5-甲基-4-(哌啶-4-基)苯胺二盐酸盐的制备方法 | |
EP4073056B1 (en) | Process for the preparation of lasmiditan and of a synthesis intermediate | |
CN109503513A (zh) | 一种非布司他中间体的“一锅法”合成方法 | |
CN107200683A (zh) | 一种用于治疗ⅱ型糖尿病达格列净中间体的制备方法 | |
CN107540575B (zh) | 一种西他列汀中间体的制备方法 | |
CN104860881A (zh) | 8-(硝基甲基)喹啉类化合物和8-甲氨基四氢喹啉类化合物的合成方法 | |
CN107200708B (zh) | 一种维莫德吉的制备方法 | |
CN112079772A (zh) | 一种4-三氟甲基烟酸中氨化反应的方法 | |
CN106854200A (zh) | 色瑞替尼及其中间体的制备方法 | |
CN104892481B (zh) | 一种提高氟咯草酮环化合成收率的工艺 | |
CN102675117A (zh) | 3-(5-硝基环己-1-烯基)丙烯酸和其酯的合成 | |
CN111333568B (zh) | 一种2-氯-5-甲基吡啶和2,3-二氯-5-甲基吡啶的选择性合成方法 | |
CN110713434B (zh) | 具有抗癌活性化合物的中间体及其制备方法和应用 | |
CN104245692B (zh) | 用于制备高纯度methiozolin的工业方法 | |
JP3282357B2 (ja) | ピペロナールの製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of vermodge Effective date of registration: 20211229 Granted publication date: 20210817 Pledgee: Shandong Tonghong import and Export Co.,Ltd. Pledgor: Xinfa pharmaceutical Co.,Ltd. Registration number: Y2021980016873 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220518 Granted publication date: 20210817 Pledgee: Shandong Tonghong import and Export Co.,Ltd. Pledgor: Xinfa pharmaceutical Co.,Ltd. Registration number: Y2021980016873 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |